Lee Rodne - Anteris Technologies CEO, Managing Director and Executive Director

AMEUF Stock  USD 14.70  0.83  5.34%   

CEO

Mr. Lee Eric Rodne has resigned as Chief Executive Officer Managing Director Executive Director of the Company. effective 30 June 2016. He has over 15 years of leadership experience in healthcare technology medical devices and mining renewable energy sectors in North America UK and Australia. Mr. Rodne was in executive leadership roles in both public and private enterprises
Professional MarksMBA
Phone61 13 0055 0310
Webhttps://www.anteristech.com
Rodne also led consulting services to the U.S. Healthcare, Device and Technology industries including Hospitals, Clinics, MultiNational Medical Device companies, Healthcare Insurance markets and various technology driven companies. He holds an MBA from the University of St. Thomas, Minnesota and a B.A. degree in Business Management from St. John’s University, Minnesota.

Anteris Technologies Management Efficiency

The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 4.07 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Anteris Technologies has a current ratio of 4.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Anteris Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Anteris Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Anteris Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Anteris to invest in growth at high rates of return. When we think about Anteris Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

Jeffrey FrelickBone Biologics Corp
58
Steven FosterTenon Medical
56
Anteris Technologies Ltd operates as a structural heart company. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Admedus operates under Medical Devices classification in the United States and is traded on OTC Exchange. Anteris Technologies [AMEUF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Anteris Technologies Leadership Team

Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Stephen Mann, CFO and Company Secretary
Maja McGuire, Company Secretary
Tanya Costello, Company Secretary
AC FAA, Exec
William Rowley, Non-Executive Director
Michael Oswell, Vice President - Development
Julian Chick, COO
Mark Ziirsen, CFO
Mathew Ratty, Non-Executive Director
John Seaberg, Non-Executive Independent Director
Peter Turvey, Non-Executive Director
Lynne Bradshaw, Director of Marketing
Lishan Zhang, Non-Executive Director
Michael Bennett, Executive Director
Tanya Mangold, Company Secretary & Legal Counsel
Lee Rodne, CEO, Managing Director and Executive Director
Wayne Paterson, Non-Executive Independent Director
Helen Wray, Vice President of Operations
Catherine Costello, CFO, Interim Executive Director, Company Secretary
Kiran Bhirangi, Chief Medical Officer
Simon Buckingham, Non-Executive Director
Wenyi Gu, Director
Yanheng Wu, Non-Executive Director
Steve Denaro, Director
Christopher Catlow, Non-Executive Chairman of the Board
Matthew McDonnell, Chief Officer
David Denis, Chief Officer
Stephen Denaro, Independent Sec
Chris Olig, Bus Director
Danny Zanardo, Commercial International
MPH MD, Chief Board

Anteris Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Anteris Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anteris Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anteris Technologies will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Anteris Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anteris Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anteris Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anteris Technologies to buy it.
The correlation of Anteris Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anteris Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anteris Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anteris Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anteris Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Anteris Pink Sheet analysis

When running Anteris Technologies' price analysis, check to measure Anteris Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anteris Technologies is operating at the current time. Most of Anteris Technologies' value examination focuses on studying past and present price action to predict the probability of Anteris Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anteris Technologies' price. Additionally, you may evaluate how the addition of Anteris Technologies to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Anteris Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anteris Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anteris Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.